🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07412184
Recruiting Not applicable

Research and Clinical Validation of a Wearable Device-Based Remote Rehabilitation System for Postoperative Rotator Cuff Injury

NCT07412184 · tracked via the Priya Life Science China tracker
Sponsor
Peking University Third Hospital
Phase
Not applicable
Started
2026-01-23
Last updated
2026-03-10

Condition(s) studied

Rotator Cuff Tear

Investigational drug(s) / intervention(s)

Wearable device rehabilitationOffline Traditional Rehabilitation

Wearable device rehabilitation: Patients with rotator cuff tears wear sensors and undergo training in conjunction with 'Fugu Medical'.

Offline Traditional Rehabilitation: Offline Traditional Rehabilitation

Study summary

This study included patients who underwent their first shoulder rotator cuff surgery at Peking University Third Hospital, diagnosed with small to medium rotator cuff tears based on MRI results. Participants were randomly divided into an online wearable device training group and an offline traditional rehabilitation group, with 36 individuals in each group. Before testing began, patients were ensured to participate voluntarily and had signed informed consent forms.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years; * First-time rotator cuff injury surgery and received surgical treatment at Peking University Third Hospital; * MRI shows a tear with a maximum diameter \<3 cm, confirmed by at least three musculoskeletal rehabilitation radiologists; * Possess a mobile device with internet access (e.g., smartphone or tablet) capable of using mobile applications; * Able to complete the planned study and follow-ups within 6 months after discharge; * No visual, hearing, cognitive, or communication impairments; * Able to provide informed and valid consent to participate in the study. Exclusion Criteria: * Presence of serious cardiovascular or cerebrovascular diseases, or cervical spondylosis with nerve damage; * Presence of cognitive impairment or vision problems; * Stroke, rheumatic disease, neurological disorders, or diseases limiting overall physical function or cardiopulmonary function within the past 2 years; * No prior history of shoulder joint injury, and having undergone other surgeries within the past 6 months; * Patients who cannot complete the entire cycle or drop out midway; * Presence of serious postoperative complications, such as wound infection, venous thromboembolism, etc.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Peking University Third Hospital Beijing China Recruiting

More Peking University Third Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07412184 on ClinicalTrials.gov ↗ ← All trials in China